Skip to main content
Premium Trial:

Request an Annual Quote

Anagnostics Taps Ramcon to Sell HybCell Array Platform in Nordic Region


Anagnostics said this week that Ramcon will sell its HybCell tests to customers in Denmark, Finland, Iceland, Norway, and Sweden.

Specifically, Ramcon will offer Anagnostics' drugs of abuse tests. The immunochemical assays rely on urine or saliva samples to semi-quantitatively test for drugs of abuse and psychotropic substances using the firm's cylindrical HybCell array platform. Ramcon will also sell Anagnostics' recently launched compact-sequencing-based pharmacogenetics tests (BAN 10/26/2010).

Anagnostics has expanded its reach via similar partnerships. The St. Valentin, Austria-based firm has inked deals with Cell.Eng to represent it in Italy, Invicon to sell its products in Germany, and Biogenetix to represent it in the Romanian market.

Birkerød-based Ramcon employs 24 sales support and service personnel. The company represents other players in the array market, including French scanner firm Innopsys, Italian biochip maker Silicon Biosystems, and Affymetrix's Panomics business.

Further details of the deal were not discussed.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.